Form D · Other

ASP Isotopes Inc.

Dallas, TX · CIK 0001921865

Offering snapshot reported Jul 17, 2026 · SEC filing

Reported sold
$109M
Offering amount: $109M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 15, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 17, 2026Initial$109,181,606No comparison11SEC filing
Mar 21, 2023Initial$5,000,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-591367
109,181,606 of the aggregate principal amount of, plus accrued unpaid interest on, convertible promissory notes previously issued by a subsidiary of the Issuer have been exchanged for common stock of the Issuer.

Source: Form D, filed Jul 17, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Ainscow Executive
Donald Ainscow Executive
Joshua Donfeld Director
Michael Gorley Director
Ralph L. Hunter, Jr. Director
Heather Kiessling Executive
Paul E. Mann Director, Executive
Sipho N. Maseko Director
Duncan Moore Director
Robert Ryan Director
Hendrik Strydom Director
Sergey Vasnetsov Director
Todd Wider Director

Issuer details

Industry: Other (See others in industry)

Address:
2200 Ross Avenue, Suite 4575 E
Dallas, TX, 75201